← Eichor
Study identifier: NCT06977906 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Improved Robotic-Assisted Radical Prostatectomy for Locally Advanced Prostate Cancer: Bladder Suspension and Preliminary Outcomes

Condition: Robotic-Assisted Radical Prostatectomy · Locally Advanced Prostate Cancer · Bladder Suspension  ·  Sponsor: First Affiliated Hospital of Fujian Medical University

PhaseNA
Planned participants300
Who can joinMale, N/A to no upper limit
Healthy volunteersNo

About this study

This study is a prospective, single-center clinical trial. It aims to establish an improved robotic-assisted radical prostatectomy for treating locally advanced prostate cancer. The technique evaluates the impact of preserving the anterior peritoneum of the bladder on postoperative bladder descent and urinary control recovery. A retrospective analysis compares this modified approach with traditional anterior approach surgery, assessing differences in oncological outcomes, early functional recovery, and postoperative complication rates. The goal is to provide new theoretical foundations and technical support for the prevention and treatment of postoperative urinary incontinence.

This description comes directly from the study's public registry record.

Talk to the study team

Xu Ning, Dr.  ·  +8613235907575  ·  drxun@fjmu.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

first hospital affiliated of Fujian medical universityFuzhou, Fujian, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06977906